Stoychev & Stoycheva commented on the importan Di Maura EU VAT case in TV Europe on 23 July 2018. You can see how the conversation went by reviewing the interview herein below.
Abstract The pharmaceutical industry bears significant costs for research and development as well as the unpredictability of whether a new medicinal product shall reach the pharmaceutical market. Once a medicinal product is launched onto the market, the profits from this medicinal product should compensate the costs incurred for the medicinal products which did not reach
АД "Стойчев и Стойчева" е модерното адвокатско дружество, където добрите практики и технологиите се срещат. Изключително съм доволен от техните услуги в сферата на данъчното и трудовото право и ги препоръчвам на всички.
